Related Experiment Videos
[A case of anaplastic thyroid carcinoma]
M Danzi1, U Robustelli, M Fabozzi
1III Divisione di Chirurgia Generale Oncologia Chirurgica, Università degli Studi di Napoli Federico II.
Il Giornale Di Chirurgia
|January 12, 1999
Summary
Anaplastic thyroid carcinoma is aggressive, but this patient survived over 20 months post-diagnosis. Treatment included surgery, chemotherapy, and radiotherapy, offering hope for extended survival.
Area of Science:
- Oncology
- Endocrinology
- Surgical Oncology
Background:
- Anaplastic thyroid carcinoma (ATC) is a rare and highly aggressive thyroid malignancy.
- Prognosis for ATC is typically poor, with limited survival rates.
Observation:
- This case details an ATC patient who survived over 20 months post-diagnosis.
- The patient received a multimodal treatment approach.
Findings:
- The patient underwent total thyroidectomy, cisplatin and doxorubicin chemotherapy, and 5000 Gy radiotherapy.
- This aggressive treatment regimen contributed to prolonged survival.
Implications:
- Multimodal therapy may improve survival outcomes in select ATC patients.
- Further research into optimal ATC treatment strategies is warranted.